The brainstem area postrema (AP) has been suggested to be one potential site of lithium's action. In order to determine whether the AP, as a central action site of lithium, is involved in the hypothalamic-pituitary-adrenal (HPA) activation by lithium, we examined lithium-induced expression of inducible cAMP early repressor (ICER) gene in the adrenal gland of rat with lesion of AP. The adrenocortical ICER expression has been suggested to be a marker for the HPA axis activation. Sprague-Dawley rats with lesion or sham lesion of AP received intraperitoneal injection of 0.15 M LiCl at a dose of 12 ml/kg. One hour after the injection, rats were transcardially perfused with fixative and the adrenal glands were processed for ICER mRNA in situ hybridization. ICER mRNA levels in the adrenal cortex of sham lesion rats were significantly increased by lithium, compared to NaCl controls, and this increase was not affected by AP lesion. Our results suggest that the area postrema may not be involved in lithium's action to activate the HPA axis.
INTRODUCTION
Intraperitoneal injection of lithium chloride has been widely used as conventional stimulus to produce conditioned taste aversion (CTA) for its toxic effect. It has been reported that intraperitoneal administration of lithium chloride activates the hypothalamic-pituiatry-adrenal gland (HPA) axis in rats;
i.e. increases plasma levels of adrenocorticotrophic hormone (ACTH) and corticosterone Smotherman, 1985; Sugawara et al., 1988; Jahng et al., 2004) . Many reports have suggested that the activation of the HPA axis may play an important role in CTA learning. Blockade of the HPA activation with adrenalectomy impairs the acquisition of lithium-induced CTA in mice (Peeters and Broekkamp, 1994) . Pharmacological manipulation of the HPA system alters the strength of lithium-induced CTA in rats; i.e. dexamethasone pretreatment on the day of conditioning attenuates Revusky and Martin, 1988) , while ACTH injection enhances and prolongs (Hennessy et al., 1980) , the expression of lithiuminduced CTA. These reports suggest that the HPA axis activation by lithium may be a part of its effects as unconditioned stimulus in CTA learning.
Although lithium, besides its experimental usage, has been used clinically for over 30 years and numbers of studies related to its therapeutic effects have been done (Pilcher, 2003) , the cellular and molecular bases of the therapeutic and toxic effects of lithium still remain poorly understood. Lithium is usually administrated systemically in both therapeutic and experimental treatments. For many effects of lithium, however, the action site of lithium is unknown since, as a small ion, lithium rapidly diffuses throughout the brain and body (Stern et al., 1977) . One potential site of lithium's action in CTA learning is the area postrema (AP), a brainstem circumventricular organ. It has been reported that lesions of the AP (APX) blocks the CTA acquisition by intraperitoneal lithium (Ritter et al., 1980; Rabin et al., 1983; Ladowsky and Ossenkopp, 1986; Kosten and Contreras, 1989; Bernstein et al., 1992) , suggesting that the brainstem AP may be an essential site of lithium's action in CTA learning. However, it is not known if the brainstem AP mediates the HPA axis activation by lithium.
In order to determine whether the brainstem AP, as a central action site of lithium, is involved in the HPA activation by lithium, we examined lithiuminduced expression of inducible cAMP early repressor (ICER) gene in the adrenal gland of AP-lesioned (APX) rat. ICER is an immediate-early gene exhibiting very low basal expression levels, and its expression is induced by elevated intracellular cAMP levels. Several investigators have shown that induction of ICER expression in the HPA axis is coupled to HPA axis activation (Luckman and Cox, 1995; Della Fazia et al., 1998; Mazzucchelli and Sassone-Corsi, 1999) , and suggested that ICER expression in the adrenal cortex could serve as a marker for the activation of the HPA axis (Della Fazia et al., 1998; Spencer et al., 2005) .
MATERIALS AND METHODS

Animals
Adult male Sprague-Dawley rats (250∼300 g) were purchased (Charles River Laboratories, Wilmington, MA) and acclimated to the laboratory conditions under a 12-h light/12-h dark cycle (lights on 07:00) at 25 o C with free access to Purina rodent chow and water. Rats were weighed daily prior to treatment to minimize handling stress. Animal experiments were carried in accordance with the NIH Guidelines for the Care and Use of Laboratory Animals revised 1996. All experimental animal protocols were approved by The Florida State University Institutional Animal Care and Use Committee.
Area postrema lesion
Rats received cautery-induced area postremalesions (APX) or sham-lesions (APS). Rats were anesthetized with a cocktail of chloral hydrate (153 mg/kg; Sigma Chemical Co., St Louis, MO) and pentobarbitol (35 mg/kg; Nembutal, Butler, Columbus, OH) and placed in a stereotaxic apparatus with the head in a ventroflexed position. A midline incision was made on the back of the neck and the neck muscles were retracted. With the aid of a dissecting microscope, the atlanto-occipital membrane was punctured and removed to expose the dorsal surface of the medulla. To permit clear visualization of the AP, a small portion of the base of the skull was removed with rongeurs to enlarge the foramen magnum. The membrane covering the AP was carefully removed and a thermal lesion of the AP was made by briefly touching the structure with the tip of a small cautery. Sham-lesions were processed in an identical manner, but the AP was not touched. Rats were given with antibiotics (16 mg sulfamethoxazole/ 3.2 mg trimethoprim per day) subcutaneously and maintained on sweetened condensed milk (diluted 1：2 with water) with mutivitamin supplements for 1 week after surgery. Complete lesions were confirmed with tests of lithiuminduced CTA learning, because the APX has been reported to impair the acquisition of CTA induced by lithium (Ritter et al., 1980; Rabin et al., 1983; Ladowsky and Ossenkopp, 1986; Kosten and Contreras, 1989; Bernstein et al., 1992) .
In situ hybridization
After recovery from CTA test, the APX (n=8) and APS (n=6) rats received intraperitoneal LiCl (0.15 M, 12 ml/kg; Sigma Chemical Co., St Louis, MO). An additional 6 rats were injected with NaCl (0.15 M, 12 ml/kg) as un-operated vehicle controls. One hour after the injections, rats were overdosed with sodium pentobarbital and transcardially perfused first with heparinized saline and then with 4% paraformaldehyde in 0.1 M phosphate buffer. Adrenal glands were removed, post-fixed for 2 h and then transferred into 30% sucrose for at least 24 h prior to sectioning.
Forty micron-thick sections of the adrenal glands were cut on a freezing, sliding microtome (HM440E, Microm Co., Germany) and collected into 20 ml glass scintillation vials containing ice-cold 2× SSC (0.3 M sodium chloride, 0.03 M sodium citrate). The SSC was pipetted off, and sections were suspended in 1 ml of prehybridization buffer (50% formamide, 10% dextran sulfate, 2× SSC, 1× Denhardt's solution, 50 mM DTT, and 0.5 mg/ml denatured herring sperm DNA), incubated for 2 h at In situ hybridization was carried out on the representative members of each experimental group at the same time under identical conditions, allowing direct comparison of mRNA expression. All adrenal sections from each group were exposed to the same piece of film at the same time, allowing simple comparison within each group. Several exposures were taken to ensure that films were not under-or over-exposed. Exposure times varied from 12 to 48 h to obtain autoradiographic images within a linear range of optical density after development in Kodak D-19 developer.
Image analysis and statistics
Images on the autoradiographic films were analyzed using a custom software program (MindsEye 1.26b, T. Houpt) as we previously described (Spencer et al., 2005) . Densitometry was restricted to hand-drawn outlines of the adrenal cortex or medulla. Data were analyzed by analysis of variance (ANOVA) and Tukey HSD post-hoc comparisons using the SPSS statistical software package (SPSS, Chicago, IL) and presented by means± SEM. The level of significance was set at p≤0.05. Fig. 1 shows a marked increase of ICER mRNA expression in the adrenal cortex of rat by 1 h of intraperitoneal LiCl (0.15 M, 12 ml/kg), in accordance with previous reports suggesting that the adrenocortical ICER expression could serve as a marker for the activation of the HPA axis (Della Fazia et al., 1998; Spencer et al., 2005) . Many reports have suggested that the activation of the HPA axis by lithium may be a part of its effects as unconditioned stimulus in conditioned taste aversion (CTA) learning Hennessy et al., 1980; Revusky and Martin, 1988; Peeters and Broekkamp, 1994) . The brainstem AP, assumed as the primary receptive site for lithium in the brain, is believed to be an essential brain site of lithium's action inducing CTA, because lesion of AP (APX) has been shown to block not only CTA acquisition (Ritter et al., 1980; Rabin et al., 1983; Ladowsky and Ossenkopp, 1986; Kosten and Contreras, 1989; Bernstein et al., 1992) but also acute effects of systemic lithium, such as lying-on-belly, hypothermia and delayed gastric emptying (Bern- Fig. 2 . Expression levels of ICER mRNA in the adrenal cortex and medulla of rats with lesion (APX) or sham lesion (APS) of the area postrema. Rats were perfused 1 h after an intraperitoneal LiCl (0.15 M, 12 ml/kg). Control rats received the same volume of 0.15 M NaCl instead of LiCl. ICER mRNA expression by lithium in the adrenal gland of APX rats did not differ from APS rats. Data represent means±SEM. ***p＜0.0005, **p＜0.007 vs. NaCl controls. stein et al., 1992) . Peripheral information entering the brain circumventricular organ AP could activate adjacent neurons in the nucleus tractus of solitarius (NTS) and relay to the hypothalamic paraventricular nucleus (PVN) that located at the center of the HPA axis (Norgren, 1995, Harrer and Travers, 1996; Yamamoto, 1998; Berthoud, 2002) . Systemic lithium markedly induces c-Fos expression, a conventional marker of neuronal activation, in the NTS and PVN as well as in the AP, the brain regions deeply implicated in CTA learning (Yamamoto et al., 1992; Lamprecht and Dudai, 1995; Sakai and Yamamoto, 1997; Jahng et al., 2004) . It was reported that APX abolishes the HPA axis activation and the PVN c-Fos expression by intravenous interleukin-1beta (Lee et al., 1998) . Together, it is suggested that lithium-induced activation of the HPA axis may comprise activation of the brain stem AP and lesion of AP may affect lithium-induced ICER expression in the adrenal gland.
RESULTS AND DISCUSSION
In this study, the adrenal ICER mRNA expression was examined 1 h after an intraperitoneal LiCl (0.15 M, 12 ml/kg) in the rats with APX or sham lesion of AP (APS). Systemic LiCl markedly increased ICER mRNA expression in the adrenal cortex of APS rats compared with the NaCl control group (p＜0.0005), and this increase was not affected by APX (Fig. 2) . The medullary expression of ICER mRNA was also significantly increased by an intraperitoneal LiCl regardless of surgery; i.e., ICER mRNA level in the adrenal medulla of APX rats did not differ from APS rats (Fig. 2) . These results reveal that lesion of AP does not affect the adrenal expression of ICER mRNA by lithium, and suggest that the brainstem AP may not be a necessary brain region for the HPA axis activation by lithium. Previous reports demonstrated that APX does not block several behavioral and physiological effects of lithium, such as oxytocin or vasopressin release (Carter and Lightman, 1987) , anorexia (Curtis et al., 1994) , or decreased heart rate (Kosten and Contreras, 1989) . Also, neuronal activation, i.e., c-Fos expression, by systemic lithium in several brain regions was not blocked by APX (Spencer et al., 1999) . Together, it is concluded that the AP may not be the only receptive site for the brain's detection of lithium, and other afferent pathways including vagal or spinal afferents may contribute to the activation of the HPA axis by systemic lithium. That is; visceral malaise by intraperitoneal lithium (Bernstein et al., 1992) could be relayed to the hypothalamus via the NTS as stressful stimuli and contribute to the HPA axis activation.
We have previously demonstrated that dexamethasone pretreatment completely blocks the adrenal ICER expression by systemic lithium, and further, central lithium administrated in the brain lateral ventricle induces ICER mRNA expression in the adrenal cortex (Spencer et al., 2005) . Sugawara and colleagues (1988) have reported that lithium stimulates ACTH release in cultured pituitary cells. Together with our present result, it is suggested that lithium may directly act in the hypothalamus, not via area postrema, to activate the HPA axis.
In conclusion, although systemic lithium has been widely used for both clinical and experimental treatments, the cellular and molecular bases of the therapeutic and toxic effects of lithium still remain poorly understood. Further, its action site in the brain is not known. The brainstem area postrema has been suggested to be one potential site of lithium's action. Our results suggest that the area postrema may not be involved in the HPA axis activation by lithium. The site of lithium action and mechanism by which lithium acutely stimulates or chronically modulates the HPA axis activity, perhaps sympathetic outflow as well, remains to be fully elucidated.
